Patents by Inventor Lode Wyns

Lode Wyns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9518084
    Abstract: Described is an epitope tag useful in affinity-based applications. The invention further includes fusion proteins, methods for preparing fusion proteins, nucleic acid molecules encoding these fusion proteins and recombinant host cells that contain these nucleic acid molecules. The invention also relates to nanobodies and other affinity ligands specifically recognizing the epitope tag, and uses thereof in affinity-based applications.
    Type: Grant
    Filed: May 25, 2011
    Date of Patent: December 13, 2016
    Assignees: VIB VZW, Vrije Universiteit Brussel
    Inventors: Els Pardon, Jan Steyaert, Lode Wyns
  • Publication number: 20130115635
    Abstract: Described is an epitope tag useful in affinity-based applications. The invention further includes fusion proteins, methods for preparing fusion proteins, nucleic acid molecules encoding these fusion proteins and recombinant host cells that contain these nucleic acid molecules. The invention also relates to nanobodies and other affinity ligands specifically recognizing the epitope tag, and uses thereof in affinity-based applications.
    Type: Application
    Filed: May 25, 2011
    Publication date: May 9, 2013
    Inventors: Els Pardon, Jan Steyaert, Lode Wyns
  • Publication number: 20040248201
    Abstract: The invention relates to a recognition molecule capable of interacting with an active site or cleft of a target molecule. The recognition molecule includes an exposed loop structure that extends from a basic recognition unit. The loop structure is, for example, the CDR3 of a camelid species heavy chain antibody having a binding specificity for the active site or cleft of a target molecule, or a derived version of such a CDR3. The basic recognition unit can be formed by an antibody-type structure having binding affinity for the target molecule.
    Type: Application
    Filed: August 11, 2003
    Publication date: December 9, 2004
    Inventors: Serge Muyldermans, Lode Wyns